Clinical trial · Interventional
Respiratory Muscle Function Changes and Effects of Chest Physiotherapy Education Interventionin Advanced Lung Cancer
The Impact of Changes in Respiratory Muscle Function on Dyspnea, Functional Capacity, and Quality of Life in Patients With Advanced Lung Cancer & the Effects of Chest Physiotherapy Education Intervention
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose for the 1st phase of this study are to exam longitudinal changes and the impact of various treatments on the respiratory muscle function, and the relations with dyspnea, functional capacity, quality of life, 6- and 12-month respiratory morbidity, and survival status (control group). The 2nd phase of this study will investigate the potential beneficial effects of chest physiotherapy in the same patient population (intervention group).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chest physiotherapy education intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- NO_INTERVENTION
- label
- Control
- interventionNames
- Other: Chest physiotherapy education intervention
Primary outcomes (1)
- measure
- Numbers of upper respiratory infections (URI) and respiratory infection related hospitalizations
- timeFrame
- 12 months after study entry
- description
- Numbers of URIs and respiratory infection related hospitalizations were collected from out-patient and inpatient medical records.
Secondary outcomes (2)
- measure
- Funcional capacity Anxiety/depression symptom Quality of life Six- and 12-month respiratory complication morbidity and survival status
- timeFrame
- every 3 months up to 18 months post study entry
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of stage III/V lung cancer * Normal cognition (a Mini Mental State Examination score of more than/equal to 24 points) * Able to finish all tests Exclusion Criteria: * A clinical diagnosis affecting respiratory muscle function and functional activity performance (e.g. musculoskeletal disorders) * Unable to perform acceptable-quality spirometry
References
Publications (0)
Data not yet available